Erika Murce

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

High Resolution

Prostate Cancer

Computed Tomography

Top Venues

Pharmaceuticals (Basel, Switzerland)

Royal Society open science

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Erika Murce, Savanne Beekman, Evelien Spaan, Maryana Handula, Debra Stuurman, Corrina de Ridder, Yann Seimbille
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer. Molecules (Basel, Switzerland) 28 (10) (2023)
Erika Murce, Evelien Spaan, Savanne Beekman, Lilian van den Brink, Maryana Handula, Debra Stuurman, Corrina de Ridder, Simone U Dalm, Yann Seimbille
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Erika Murce, Stephen Ahenkorah, Savanne Beekman, Maryana Handula, Debra Stuurman, Corrina de Ridder, Frederik Cleeren, Yann Seimbille
Radiochemical and Biological Evaluation of 3p- C -NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Erika Murce, Erik de Blois, Sophie van den Berg, Marion de Jong, Yann Seimbille
Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers. Royal Society open science 10 (3) (2023)
Erika Murce, Erik de Blois, Sophie van den Berg, Marion de Jong, Yann Seimbille
Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers. Royal Society open science 10 (3) (2023)
Erika Murce, Stephen Ahenkorah, Savanne Beekman, Maryana Handula, Debra Stuurman, Corrina de Ridder, Frederik Cleeren, Yann Seimbille
Radiochemical and Biological Evaluation of 3p- C -NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)